InvestorsHub Logo
icon url

hc-investor

12/08/21 5:33 PM

#431 RE: blue_skies #430

Let's see what they come up with. Will certainly be interesting...
icon url

Topgun54

12/08/21 6:08 PM

#433 RE: blue_skies #430

It should be. This segment has been small since the introduction Vivaglobin in 2006. After 15 years, they claim to be the market leader with only $20 million in sales? How could they project $50million? A little research here tells you the SCIG segment is still small, perhaps under $40 million. It holds good prospects, but IVIG still scales SCIG by an 80% market share for PIDD.